TSE advisory committee
This article was originally published in The Tan Sheet
FDA's Transmissible Spongiform Encephalopathies Advisory Committee will meet on Oct. 14 in Silver Spring, Md. to hear updates on issues pertaining to TSE and bovine spongiform encephalopathies, the agency announces in a recent Federal Register notice. Topics on the agenda include new CFSAN BSE-food safety rules and a review of the worldwide BSE situation. Interested parties may submit written comments by Oct. 5 or give oral presentations during the meeting...
You may also be interested in...
Cognoa said it will submit its AI-powered digital app for early detection of autism for de novo clearance with the US FDA. See what the company’s senior medical director of clinical adoption said about it here.
Congress should give FDA more flexibility to administer orphan designations, such as the ability to revoke designations later if the disease prevalence grows beyond the rare disease threshold.
In sign of how much has changed in four years, industry might be better off if Biden takes CAP’s advice and launches ‘march-in’ actions to address pricing of COVID products.